Johnson & Johnson’s DePuy Synthes launches outpatient joint replacements

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes this week said it launched a new program for outpatient joint replacement procedures, DePuy Synthes Advantage.

The Advantage program covers hip, knee and shoulder replacements by providing education, training and professional and patient support services, Warsaw, Ind.-based DePuy Synthes said. More than 500 healthcare professionals have been trained in the outpatient program since its pilot, the company said.

The program also includes subscription-based data collection software, CareSense, and the Patient Athlete video-based “patient empowerment” program, according to DePuy Synthes.

“Outpatient joint replacement is an emerging option for healthy, motivated patients that may help them safely recover more quickly, and in the comfort of their own homes, instead of in the hospital,” DePuy Synthes Advantage director Scott Zellner said in prepared remarks. “When performed on the right patient, in the right setting, with trained staff, and leveraging innovative surgical techniques and implant technologies, these procedures have the potential to improve outcomes, speed recovery, manage costs, improve efficiency and increase patient satisfaction.

“As an industry leader in orthopaedics, we have an opportunity to support adoption of outpatient joint replacement through proven and comprehensive programs that go beyond the implant with the goals of improving clinical outcomes, increasing patient satisfaction and reducing costs,” Zellner said. “We expect more health care professionals will consider outpatient joint replacement as an important option for their patients, and we will be right there with them to provide the support they need to optimize outcomes.”

“Outpatient surgery is evolving into another layer of our healthcare model where patients are now requesting these outpatient procedures that are more value based with the goals of better outcomes, less complications and faster recovery periods,” added Dr. Mark Gittins of Ohio’s New Albany Surgical Center. “In our ambulatory surgery center we have implemented programs from DePuy Synthes Advantage such as CareSense, Patient Ambassador and surgical tray optimization, which have helped to create additional efficiencies in our center and patients certainly benefit from this new era of care.”

The post Johnson & Johnson’s DePuy Synthes launches outpatient joint replacements appeared first on MassDevice.

from MassDevice http://ift.tt/1Y9iN93